G740-0225 Screening compound: 2-[2-(4-chlorophenyl)-3,7-dimethyl-4-oxo-2H,4H,5H-pyrazolo[3,4-d]pyridazin-5-yl]-N-[(4-ethoxy-3-methoxyphenyl)methyl]acetamide

G740-0225 Screening compound: 2-[2-(4-chlorophenyl)-3,7-dimethyl-4-oxo-2H,4H,5H-pyrazolo[3,4-d]pyridazin-5-yl]-N-[(4-ethoxy-3-methoxyphenyl)methyl]acetamide
G740-0225 Screening compound: 2-[2-(4-chlorophenyl)-3,7-dimethyl-4-oxo-2H,4H,5H-pyrazolo[3,4-d]pyridazin-5-yl]-N-[(4-ethoxy-3-methoxyphenyl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G740-0225
2-[2-(4-chlorophenyl)-3,7-dimethyl-4-oxo-2H,4H,5H-pyrazolo[3,4-d]pyridazin-5-yl]-N-[(4-ethoxy-3-methoxyphenyl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G740-0225

Molecular Formula

C25H26ClN5O4 (C25 H26 ClN5 O4)

Compound Name

2-[2-(4-chlorophenyl)-3,7-dimethyl-4-oxo-2H,4H,5H-pyrazolo[3,4-d]pyridazin-5-yl]-N-[(4-ethoxy-3-methoxyphenyl)methyl]acetamide

IUPAC name

2-[2-(4-chlorophenyl)-37-dimethyl-4-oxo-2H4H5H-pyrazolo[34-d]pyridazin-5-yl]-N-[(4-ethoxy-3-methoxyphenyl)methyl]acetamide

SMILES

CCOc(ccc(CNC(CN(C(c1c2C)=O)N=C(C)c1nn2-c(cc1)ccc1Cl)=O)c1)c1OC

InChI

InChI=1S/C25H26ClN5O4/c1-5-35-20-11-6-17(12-21(20)34-4)13-27-22(32)14-30-25(33)23-16(3)31(29-24(23)15(2)28-30)19-9-7-18(26)8-10-19/h6-12H,5,13-14H2,1-4H3,(H,27,32)

InChI Key

DJXFUTGCWYXYMC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15030967

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

495.97

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.119

Distribution Coefficient, logD

3.119

Water Solubility, LogSw

-3.81

Polar Surface Area

80.654

Acid Dissociation Constant (pKa)

15.13

Base Dissociation Constant (pKb)

1.16

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.00

G740-0225 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Anti-HIV1 Library (19540 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with G740-0225 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G740-0225?
Check Price and Availability of G740-0225, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G740-0225 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G740-0225
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G740-0225
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G740-0225 available by request